GO Main Menu Go Main Contents Go Bottom Menu
  • 54
    Celltrion Launches Human Clinical Trial of Potenti..
    Celltrion launches human clinical trial of potential COVID-19 antiviral antibody treatment following positive pre-clinical results ·The Phase I study of Celltrion’s COVID-19 antiviral antibody treatment candidate in healthy volunteers is set for co…
    2020-07-17
  • 53
    Celltrion Healthcare receives positive CHMP opinio..
    Celltrion Healthcare receives positive CHMP opinion for an additional five indications for Remsima® SC including for use in inflammatory bowel disease and ankylosing spondylitis ·The positive Committee for Medicinal Products for Human Use (CHMP) opi…
    2020-06-29
  • 52
    Celltrion to expand COVID-19 testing portfolio to ..
    Celltrion to expand COVID-19 testing portfolio to include both antigen and antibody testing kits Celltrion plans to launch point-of-care antigen testing (POCT) kit in July in collaboration with BBB, a South Korean healthcare techno…
    2020-06-16
  • 51
    New Phase II data indicate regimen of Truxima® (bi..
    New Phase II data indicate regimen of Truxima®(biosimilar rituximab), lenalidomide and acalabrutinib (R2A) may be well tolerated and effective in relapsed/refractory aggressive B-cell lymphoma Data from a Phase II trial show a regimen o…
    2020-06-15
  • 50
    Celltrion Healthcare showcases positive 1-year dat..
    Celltrion Healthcare showcases positive 1-year data and budget impact analysis for novel subcutaneous formulation of infliximab in patients with rheumatoid arthritis at the European E-Congress of Rheumatology 2020 1-year data from a ran…
    2020-06-04
  • 49
    Celltrion announces positive pre-clinical results ..
    Celltrion announces positive pre-clinical results for COVID- 19 antiviral antibody treatment, showing improvement in recovery time ·Pre-clinical data for Celltrion’s antiviral antibody treatment candidate demonstrate a 100-fold reduction in viral lo…
    2020-06-01
  • 48
    New data show first-line triplet regimen of pembro..
    New data show first-line triplet regimen of pembrolizumab, Herzuma®(biosimilar trastuzumab) and chemotherapy are effective in treatment of HER2-positive advanced gastric cancer Data from a phase Ib/II trial show a first-line triple combination…
    2020-05-29
  • 47
    Celltrion completes neutralisation test on candida..
    Celltrion completes neutralisationtest on candidate monoclonal antibodies (mAbs) for COVID-19 antiviral antibody treatment ·Celltrion completes selection of therapeutic antibodies which are most potent for neutralising the virus ·Celltrion expects …
    2020-04-13
  • 46
    Celltrion’s COVID-19 Antiviral Treatment Enters th..
    Celltrion’s COVID-19 antiviral treatment enters the next phase of development ·Celltrion initiates the 2nd stage; selecting the therapeutic antibodies which are most potent for neutralising the infection ·Celltrion completed the 1st phase of screen…
    2020-04-03
  • 45
    Celltrion accelerates development of COVID-19 anti..
    Celltrion accelerates development of COVID-19 antiviral treatment and aims to launch rapid self-testing kit Celltrion completes first step of developing an antiviral treatment to fight COVID-19 and hopes to begin human clinical trials in the …
    2020-03-23